Compare BioNTech SE - ADR (BNTX) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs Tilray Brands Inc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Tilray Brands Inc trades at $4.77 (market cap $649.42M). The key difference: BioNTech SE - ADR is far larger — about 35.9× Tilray Brands Inc's market cap, and BioNTech SE - ADR is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals.
| BNTX | TLRY | |
|---|---|---|
Market Cap | $23.31B | $649.42M |
Sector | Health | Health |
52-Week High | $119.34 | $21.00 |
52-Week Low | $83.89 | $3.88 |
Enterprise Value | $6.60B | $816.55M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
